Related Experiment Video
Updated: Oct 12, 2025

Multimodality Diagnosis of Mesenteric Ischemia
Published on: July 21, 2023
Systemic Therapy for Microsatellite Instability Small Bowel Adenocarcinoma With Mesenteric Vascular Embolism as
Zhongyi Dong1, Xiang Xia1, Zizhen Zhang1
1Department of Gastrointestinal Surgery, Renji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, China.
Abstract:
Background: Small bowel adenocarcinoma are relatively rare tumors of the digestive system. Due to the lack of specific screening methods, patients are often diagnosed at an advanced stage. At present, there is no specific surgical guidance and chemotherapy regimen for small bowel adenocarcinoma. Here, we report a rare small bowel adenocarcinoma case with mesenteric vascular embolization and microsatellite instability, in which palliative surgery combined with chemotherapy and anti-Programmed cell death protein 1(PD-1) therapy resulted in complete remission. Case Presentation: The patient was a 55-year-old man who was admitted for suspected small bowel adenocarcinoma combined with incomplete ileus, mesenteric vascular occlusion and distant metastasis. We performed palliative surgery to remove adenocarcinoma as well as relieve obstruction. Then according to the pathological and immunohistochemical results (Stage IV and microsatellite instability), we used XELOX regimen combined with anti-PD-1 therapy. In last 2 years follow up, this patient achieved complete remission. Conclusions: The possibility of small intestinal tumor should be considered in patients with mesenteric vascular obstruction. PD-1 blockade is an effective therapy for small bowel adenocarcinoma with microsatellite instability.
Insights
Small bowel adenocarcinoma, a rare digestive tumor, can present with mesenteric vascular issues. A combination of surgery, chemotherapy, and anti-Programmed cell death protein 1 (PD-1) therapy led to complete remission in a Stage IV case.
Area of Science:
- Gastroenterology
- Oncology
- Surgical Oncology
Background:
- Small bowel adenocarcinoma is a rare malignancy often diagnosed at advanced stages due to limited screening.
- Current treatment lacks specific surgical and chemotherapeutic guidelines.
- Mesenteric vascular complications can be associated with small intestinal tumors.
Observation:
- A 55-year-old male presented with symptoms suggestive of small bowel adenocarcinoma, including incomplete ileus, mesenteric vascular occlusion, and metastasis.
- Palliative surgery was performed to resect the adenocarcinoma and alleviate the obstruction.
- Pathological and immunohistochemical analysis revealed Stage IV adenocarcinoma with microsatellite instability.
Findings:
- The patient received the XELOX chemotherapy regimen combined with anti-Programmed cell death protein 1 (PD-1) therapy.
- Following treatment, the patient achieved complete remission.
- A two-year follow-up confirmed the sustained remission.
Implications:
- Mesenteric vascular obstruction should prompt consideration of small intestinal tumors.
- Anti-PD-1 therapy demonstrates efficacy in treating microsatellite instability-high small bowel adenocarcinoma.
- This case highlights a successful multimodal treatment approach for advanced small bowel adenocarcinoma.
More Related Videos
05:43The Role of Anatomical Dissection in Defining Colic and Small Bowel Artery Lymphovascular Bundles in the D3 Volume of Small and Large Bowel Mesentery
Published on: August 1, 2025
07:12Targeting the Rat's Small Bowel: Long-Term Infusion into the Superior Mesenteric Artery
Published on: April 8, 2021